Oncotelic Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.7M | $23.6M | $568.8K |
| FY2022 | $16.9M | $36.1M | $241.5K |
| FY2023 | $18.4M | $30.0M | $170.4K |
| FY2024 | $19.2M | $26.7M | — |
| FY2025 | $131.4M | $393.1M | — |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $15.7M | $23.6M | $568.8K |
| FY2022 | $16.9M | $36.1M | $241.5K |
| FY2023 | $18.4M | $30.0M | $170.4K |
| FY2024 | $19.2M | $26.7M | — |
| FY2025 | $131.4M | $393.1M | — |